Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Nutrition supplement maker Glanbia shares surge after earnings outlook upgrade
    Finance

    Nutrition supplement maker Glanbia shares surge after earnings outlook upgrade

    Published by Global Banking & Finance Review®

    Posted on August 13, 2025

    2 min read

    Last updated: January 22, 2026

    The image depicts the acquisition of Esso's 1,200 fuel stations by an Italian consortium, highlighting the strategic impact on Italy's fuel distribution network.
    Italian consortium acquiring Esso fuel stations in strategic financial deal - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:innovationfinancial managementinvestment

    Quick Summary

    Glanbia's shares rose 10% after it upgraded its earnings outlook, signaling recovery from earlier market challenges. The company expects improved earnings per share and sees growth in key sectors.

    Table of Contents

    • Glanbia's Earnings Outlook and Market Response
    • Company Performance and Growth
    • Challenges and Market Conditions

    Glanbia Shares Jump 10% Following Positive Earnings Outlook Update

    Glanbia's Earnings Outlook and Market Response

    DUBLIN (Reuters) -Shares in nutrition supplement maker Glanbia opened 10% higher on Wednesday after it increased its full-year earnings outlook and said it was overcoming challenges that pushed its shares to a two-year low in February.

    Company Performance and Growth

    Glanbia said it expected full-year earnings per share of $1.30-$1.33 on an adjusted basis, up from its previous forecast of $1.24-$1.30. The firm earned $1.40 per share last year.

    Challenges and Market Conditions

    The U.S.-focused company reported "strong growth" in its Health & Nutrition and Dairy Nutrition businesses and "sequential improvement" in Performance Nutrition.

    The company is not seeing any consumer weakness in the United States and the impact of tariffs is "manageable", Chief Financial Officer Mark Garvey said in an interview following the release of the results.

    "You never know with today's market when you are, but certainly I feel a lot better than I did three months ago," Garvey said.

    Glanbia in February issued a profit warning, in part due to a rise in the cost of whey - a key ingredient in the protein powders and shakes popular with gym goers. Whey prices now look likely to moderate next year as more capacity comes on stream, Garvey said.

    The firm in April reported lower revenue from performance nutrition products in U.S. club retailers and speciality channels, but in the second quarter of the year saw positive volumes and pricing through those channels, Garvey said.

    "We're going to pass that club channel challenge that we had," Garvey said.

    Glanbia shares were trading at 13.54 euros at 0730 GMT, up 47% from their low of 9.20 euros on April 9.

    (Writing by Conor HumphriesEditing by Christina Fincher)

    Key Takeaways

    • •Glanbia shares increased by 10% following an earnings outlook upgrade.
    • •The company expects full-year earnings per share of $1.30-$1.33.
    • •Glanbia is overcoming previous challenges in the market.
    • •Whey prices are expected to moderate next year.
    • •Positive growth seen in Health & Nutrition and Dairy Nutrition sectors.

    Frequently Asked Questions about Nutrition supplement maker Glanbia shares surge after earnings outlook upgrade

    1What is earnings per share?

    Earnings per share (EPS) is a financial metric that indicates the profitability of a company by dividing its net income by the number of outstanding shares.

    2What is market capitalization?

    Market capitalization is the total market value of a company's outstanding shares, calculated by multiplying the share price by the total number of shares.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostJaguar Land Rover to recall over 121,500 US vehicles due to suspension knuckle issue, NHTSA says
    Next Finance PostUK's Persimmon eyes 2026 sales growth but margin concerns weigh on shares